Recently added articles from Biopharm International:
SAFC Pharma Expands Facility to Bolster Biologies Manufacturing
Nov 01, 2009; ... SAFC Pharma has announced the completion of an addition to its Carlsbad, CA, facility, which specializes in the process development and manufacturing of viral vaccines and viral therapeutics. The new expansion, designed for multi-lot campaigns, includes dedicated cell expansion, bioreactor ...
New USP Standards for Heparin Include New Identity and Potency Tests
Nov 01, 2009; ... New heparin standards recently adopted by the United States Pharmacopeia (USP) include new tests to ensure the quality of the drug. The revisions to the USP heparin monograph, which became official on October 1, were made in response to incidents in 2007-2008 where heparin was intentionally ...
DASGIP Adds to iPhone Offerings for Scientists
Nov 01, 2009; ... In keeping with the growing trend of iPhone applications for every conceivable convenience, DASGIP AG (Juelich, Germany) has launched an iPhone application for accessing bioprocesses online. The company released its Remote Control Suite at the Biotechnica, which was held on October 6-8 ...
FDA Approves Biologic to Treat Psoriasis
Nov 01, 2009; ... The US Food and Drug Administration has approved Stelara (ustekinumab), a biologic manufactured by Centocor Ortho Biotech, Inc. (Horsham, PA), for adults who have a moderate to severe form of psoriasis. Stelara is a monoclonal antibody that mimics the body's own antibodies that are ...
Vaccine Report
Nov 01, 2009; ... GSK's Adjuvanted Cervical Cancer Vaccine Gets Favorable Recommendation from FDA Advisory Committee The US Food and Drug Administration's Vaccines and Related Biological Products Advisory Commiltee voted that clinical data support both the efficacy and safety of Cervarix, ...